Integrating medications for opioid use disorder into a 12-step treatment program
Integrating medications for opioid use disorder into a 12-step treatment program
Medications for opioid use disorder like buprenorphine/naloxone, often known by the brand name Suboxone, are life-saving, empirically supported interventions. A major barrier to their adoption in residential and other common 12-step-focused programs is the perceived tension between use of these medications – particularly agonists such as methadone and buprenorphine – and the “abstinence-based” 12-step philosophy. The authors of this study show that it is feasible to provide these medications within a 12-step oriented treatment program. They also provide a valuable first look at outcomes for the patients who participated. (Recovery Research Institute, USA, Oktober 2019)
https://www.recoveryanswers.org/research-post/medication-therapy-12-step-integration/